Cambrex Corporation provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Its development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. The company offers extensive experience developing processes to manufacture drug substances for clients' use in toxicology studies, clinical studies and commercial supply. Its broad range of services include route selection, process and analytical development, process optimization and scale-up, safety assessments and more.